Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06180525
Other study ID # RS1793/22(2702)
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 1, 2022
Est. completion date June 1, 2024

Study information

Verified date March 2024
Source Regina Elena Cancer Institute
Contact Nicola Salducca
Phone 06-5266.6894
Email nicola.salducca@ifo.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to evaluate the osseointegration of 3D printed porous collars in hip and knee resection prostheses, in order to eliminate one of the causes of diaphyseal osteolysis, which often lead to loosening of the implants, and therefore to guarantee a further improvement in fixation of the implants in terms of both primary and secondary stability.


Description:

Non-interventional, retro-prospective, non-pharmacological multicenter pilot study. The objective of the study is the radiological and clinical evaluation of collar osteointegration porous 3D printed in hip and knee resection prostheses. Aims to enroll patients undergoing resection prosthesis surgery hip and knee with the use of 3D printed porous collars, performed according to normal practice clinic at the institutions participating in the study. It is structured in a retrospective part which will evaluate the patients for whom follow-up data is available at the time of the start of the study up to at least 1 year after the operation. And a prospective part (both with regard to patients not yet subjected to intervention, at the start of the study, according to the inclusion criteria, both regarding those in follow-up for whom data are not available according to the time of observation required (1 year)) which will begin once all the necessary authorizations have been obtained administrative requests.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - age > 18 years at the time of surgery. - patients undergoing hip and knee resection prosthesis surgery with the use of collars porous 3D printed. - date of intervention: starting from the regular entry into use of 3D printed porous collars at the reference center. - Patients operated on for primary tumor outcomes. - Patients operated on for infection. - Patients operated for revisions with severe loss of bone substance. - Patients capable of giving informed consent and obtaining written informed consent (prospective part/patients in follow-up). Exclusion Criteria: - Patients lost to follow-up and/or for whom radiographic and clinical documentation is not available corresponding to the post-operative moment and the clinical follow-up visit (6 months and 1 years).

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Italy "Regina Elena" National Cancer Institute Rome

Sponsors (4)

Lead Sponsor Collaborator
Regina Elena Cancer Institute Azienda Ospedaliera Città della Salute e della Scienza di Torino, Istituto Ortopedico Rizzoli, San Filippo Neri General Hospital

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Radiological evaluation Osseointegration will be assessed by x-ray analysis 6 months and 1 year after surgery 6 months and 1 year
Secondary QoL evaluation Patient satisfaction/quality of life will be assessed 6 months and 1 year after surgery validated clinical questionnaire (Oxford score).
Bone remodeling will be evaluated by x-ray analysis 6 months and 1 year after surgery. Number of adverse events of any nature during follow-up. Highlight any inter-observer variability in the detection of radiological measurements.
6 months and 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05515068 - Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
Completed NCT02862288 - Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. Phase 1/Phase 2
Withdrawn NCT01679691 - The Epidural Anesthesia on the Intra-operative and Post-operative Amount of Bleeding Post Lower Limb Salvage Surgery N/A
Recruiting NCT04178044 - Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection Phase 1
Completed NCT03389724 - Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia Phase 3
Completed NCT05075889 - Utility of ICG in Benign Bone Tumors Early Phase 1
Recruiting NCT04755140 - Endoprosthesis Metal Toxicity Study
Not yet recruiting NCT03427632 - Role of Percutaneous Vertebroplasty in Treatment of Vertebral Tumors N/A
Completed NCT04798326 - Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults Phase 1
Active, not recruiting NCT04104750 - The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,
Completed NCT00598741 - Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors N/A
Completed NCT02398058 - Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) Phase 1
Recruiting NCT06171282 - A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors Early Phase 1
Not yet recruiting NCT06376682 - EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy N/A
Enrolling by invitation NCT05772312 - Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery
Recruiting NCT05779670 - Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
Completed NCT05732558 - Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy N/A
Completed NCT04955522 - Multimodal Imaging Analysis of Spinal Tumors
Recruiting NCT05631002 - Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors
Recruiting NCT06008483 - A Dose Finding Study to Treat Bone Tumor(s) Phase 1